Anti-proliferative and pro-apoptotic effects of tectorigenin on hepatic stellate cells

Figure 1 Effects of tectorigenin on the viability of hepatic stellate cell -T6 (A) and -L02 cells (B). Cells were treated for 12, 24 and 48 h with tectorigenin at 10, 20, 40, 60, 80 and 100 μg/mL, respectively, followed by assessing the cell viability relative to that of untreated cells (= control). Bars represent mean ± SD.